You have free access to this content

Hepatology

Cover image for Hepatology

November 2011

Volume 54, Issue 5

Pages 1493–1895

  1. Obituary

    1. Top of page
    2. Obituary
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Steatohepatits/Metabolic Liver Disease
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Liver Injury/Regeneration
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
      In Memoriam: Emmet B. Keeffe, M.D. (pages 1493–1495)

      Aijaz Ahmed and Carlos O. Esquivel

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24687

  2. Editorials

    1. Top of page
    2. Obituary
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Steatohepatits/Metabolic Liver Disease
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Liver Injury/Regeneration
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
      Pentoxifylline for steatohepatitis: Magic bullet or smoking gun? (pages 1496–1499)

      Richard K. Sterling and Arun J. Sanyal

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24612

    2. You have free access to this content
    3. You have free access to this content
  3. Viral Hepatitis

    1. Top of page
    2. Obituary
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Steatohepatits/Metabolic Liver Disease
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Liver Injury/Regeneration
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
      The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A (pages 1506–1517)

      Karla J. Helbig, Nicholas S. Eyre, Evelyn Yip, Sumudu Narayana, Kui Li, Guillaume Fiches, Erin M. McCartney, Rohit K. Jangra, Stanley M. Lemon and Michael R. Beard

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24542

    2. You have free access to this content
      Impact of IL28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with peginterferon alpha-2a (40KD)/ribavirin (pages 1518–1526)

      Thomas-Matthias Scherzer, Albert Friedrich Stättermayer, Michael Strasser, Hermann Laferl, Andreas Maieron, Rudolf Stauber, Christian Datz, Emina Dulic-Lakovic, Petra Steindl-Munda, Harald Hofer and Peter Ferenci

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24546

    3. You have free access to this content
      Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial (pages 1527–1537)

      Marc G. Ghany, Hae-Young Kim, Anne Stoddard, Elizabeth C. Wright, Leonard B. Seeff, Anna S.F. Lok and the HALT-C Trial Group

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24550

    4. You have free access to this content
      Retreatment with telaprevir combination therapy in hepatitis C patients with well-characterized prior treatment response (pages 1538–1546)

      Andrew J. Muir, Fred F. Poordad, John G. McHutchison, Mitchell L. Shiffman, Thomas Berg, Peter Ferenci, E. Jenny Heathcote, Jean-Michel Pawlotsky, Stefan Zeuzem, Henk W. Reesink, Geoffrey Dusheiko, Emily C. Martin, Shelley George, Robert S. Kauffman and Nathalie Adda

      Version of Record online: 24 AUG 2011 | DOI: 10.1002/hep.24549

    5. You have free access to this content
      Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care (pages 1547–1558)

      Hamish A. Innes, Sharon J. Hutchinson, Samuel Allen, Diptendu Bhattacharyya, Peter Bramley, Toby E.S. Delahooke, John F. Dillon, Ewan Forrest, Andrew Fraser, Ruth Gillespie, David J. Goldberg, Nicholas Kennedy, Scott McDonald, Allan McLeod, Peter R. Mills, Judith Morris, Peter Hayes and on behalf of the Hepatitis C Clinical Database Monitoring Committee.

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24561

    6. You have free access to this content
      Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C (pages 1559–1569)

      Lucy Golden-Mason, Kiran M. Bambha, Linling Cheng, Charles D. Howell, Milton W. Taylor, Paul J. Clark, Nezam Afdhal, Hugo R. Rosen and on behalf of the Virahep-C Study Group

      Version of Record online: 24 AUG 2011 | DOI: 10.1002/hep.24556

    7. You have free access to this content
      Vitamin D: An innate antiviral agent suppressing hepatitis C virus in human hepatocytes (pages 1570–1579)

      Meital Gal-Tanamy, Larisa Bachmetov, Amiram Ravid, Ruth Koren, Arie Erman, Ran Tur-Kaspa and Romy Zemel

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24575

    8. You have free access to this content
      Up-regulation of Hedgehog pathway is associated with cellular permissiveness for hepatitis C virus replication (pages 1580–1590)

      Steve S. Choi, Shelton Bradrick, Guan Qiang, Anahita Mostafavi, Gaurav Chaturvedi, Steven A. Weinman, Anna Mae Diehl and Ravi Jhaveri

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24576

    9. You have free access to this content
      Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C (pages 1591–1599)

      Y.-F. Liaw, J.-D. Jia, H.L.Y. Chan, K.H. Han, T. Tanwandee, W.L. Chuang, D.M. Tan, X.Y. Chen, E. Gane, T. Piratvisuth, L. Chen, Q. Xie, J.J.Y. Sung, C. Wat, C. Bernaards, Y. Cui and P. Marcellin

      Version of Record online: 4 OCT 2011 | DOI: 10.1002/hep.24555

  4. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Obituary
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Steatohepatits/Metabolic Liver Disease
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Liver Injury/Regeneration
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
      Dysregulation of the unfolded protein response in db/db mice with diet-induced steatohepatitis (pages 1600–1609)

      Mary E. Rinella, M. Shaddab Siddiqui, Konstantina Gardikiotes, Jeanne Gottstein, Marc Elias and Richard M. Green

      Version of Record online: 27 JUL 2011 | DOI: 10.1002/hep.24553

    2. You have free access to this content
      Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial (pages 1610–1619)

      Claudia O. Zein, Lisa M. Yerian, Prema Gogate, Rocio Lopez, John P. Kirwan, Ariel E. Feldstein and Arthur J. McCullough

      Version of Record online: 24 AUG 2011 | DOI: 10.1002/hep.24544

    3. You have free access to this content
      Nuclear factor high-mobility group box1 mediating the activation of toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice (pages 1620–1630)

      Liang Li, Lei Chen, Liang Hu, Yuan Liu, Han-Yong Sun, Jing Tang, Yu-Jie Hou, Yan-Xin Chang, Qian-Qian Tu, Gen-Sheng Feng, Feng Shen, Meng-Chao Wu and Hong-Yang Wang

      Version of Record online: 25 JUL 2011 | DOI: 10.1002/hep.24552

  5. Steatohepatits/Metabolic Liver Disease

    1. Top of page
    2. Obituary
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Steatohepatits/Metabolic Liver Disease
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Liver Injury/Regeneration
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      Urinary ethyl glucuronide as a novel screening tool in patients pre- and post–liver transplantation improves detection of alcohol consumption (pages 1640–1649)

      Katharina Staufer, Hilke Andresen, Eik Vettorazzi, Niels Tobias, Bjoern Nashan and Martina Sterneck

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24596

  6. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Obituary
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Steatohepatits/Metabolic Liver Disease
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Liver Injury/Regeneration
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have full text access to this OnlineOpen article
      Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance (pages 1650–1660)

      Hui-Young Lee, Andreas L. Birkenfeld, Francois R. Jornayvaz, Michael J. Jurczak, Shoichi Kanda, Violeta Popov, David W. Frederick, Dongyan Zhang, Blas Guigni, Kalyani G. Bharadwaj, Cheol Soo Choi, Ira J. Goldberg, Jae-Hak Park, Kitt F. Petersen, Varman T. Samuel and Gerald I. Shulman

      Version of Record online: 19 AUG 2011 | DOI: 10.1002/hep.24571

  7. Hepatobiliary Malignancies

    1. Top of page
    2. Obituary
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Steatohepatits/Metabolic Liver Disease
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Liver Injury/Regeneration
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
      Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma in humans (pages 1661–1678)

      Yeonghwan Kim, Miran Jang, Sangbin Lim, Hyeran Won, Kyung-Sik Yoon, Jae-Hoon Park, Hyo Jong Kim, Byung-Ho Kim, Won-Sang Park, Joohun Ha and Sung-Soo Kim

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24539

    2. You have free access to this content
      Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans (pages 1679–1689)

      Fu Yang, Ling Zhang, Xi-song Huo, Ji-hang Yuan, Dan Xu, Sheng-xian Yuan, Nan Zhu, Wei-ping Zhou, Guang-shun Yang, Yu-zhao Wang, Jing-li Shang, Chun-fang Gao, Feng-rui Zhang, Fang Wang and Shu-han Sun

      Version of Record online: 6 SEP 2011 | DOI: 10.1002/hep.24563

    3. You have free access to this content
      Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: A study of hepatocellular carcinoma (pages 1690–1706)

      Tao Sun, Bao-cun Sun, Xiu-lan Zhao, Nan Zhao, Xue-yi Dong, Na Che, Zhi Yao, Yue-mei Ma, Qiang Gu, Wen-kang Zong and Zhi-yong Liu

      Version of Record online: 21 JUL 2011 | DOI: 10.1002/hep.24543

    4. You have free access to this content
      Human hepatocellular carcinomas with “Stemness”-related marker expression: keratin 19 expression and a poor prognosis (pages 1707–1717)

      Haeryoung Kim, Gi Hong Choi, Deuk Chae Na, Ei Young Ahn, Gwang Il Kim, Jae Eun Lee, Jai Young Cho, Jeong Eun Yoo, Jin Sub Choi and Young Nyun Park

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24559

    5. You have free access to this content
    6. You have free access to this content
      MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression (pages 1729–1740)

      Jian-Hong Fang, Hui-Chao Zhou, Chunxian Zeng, Jine Yang, Yinglin Liu, Xiuzhi Huang, Jing-Ping Zhang, Xin-Yuan Guan and Shi-Mei Zhuang

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24577

  8. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Obituary
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Steatohepatits/Metabolic Liver Disease
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Liver Injury/Regeneration
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
      Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression (pages 1741–1752)

      Yoo-Mee Vanwijngaerden, Joost Wauters, Lies Langouche, Sarah Vander Perre, Christopher Liddle, Sally Coulter, Sara Vanderborght, Tania Roskams, Alexander Wilmer, Greet Van den Berghe and Dieter Mesotten

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24582

  9. Liver Injury/Regeneration

    1. Top of page
    2. Obituary
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Steatohepatits/Metabolic Liver Disease
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Liver Injury/Regeneration
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      Circulating microRNAs as potential markers of human drug-induced liver injury (pages 1767–1776)

      Philip J. Starkey Lewis, James Dear, Vivien Platt, Kenneth J. Simpson, Darren G.N. Craig, Daniel J. Antoine, Neil S. French, Neeraj Dhaun, David J. Webb, Eithne M. Costello, John P. Neoptolemos, Jonathan Moggs, Chris E. Goldring and B. Kevin Park

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24538

    3. You have free access to this content
  10. Liver Biology/Pathobiology

    1. Top of page
    2. Obituary
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Steatohepatits/Metabolic Liver Disease
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Liver Injury/Regeneration
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
      Type 2 inositol 1,4,5-trisphosphate receptor modulates bile salt export pump activity in rat hepatocytes (pages 1790–1799)

      Emma A. Kruglov, Samir Gautam, Mateus T. Guerra and Michael H. Nathanson

      Version of Record online: 30 AUG 2011 | DOI: 10.1002/hep.24548

    2. You have free access to this content
      Conditional disruption of mouse HFE2 gene: Maintenance of systemic iron homeostasis requires hepatic but not skeletal muscle hemojuvelin (pages 1800–1807)

      Konstantinos Gkouvatsos, John Wagner, George Papanikolaou, Giada Sebastiani and Kostas Pantopoulos

      Version of Record online: 24 AUG 2011 | DOI: 10.1002/hep.24547

    3. You have free access to this content
      Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis (pages 1808–1818)

      Ya-Li Jia, Lei Shi, Jun-Nian Zhou, Chun-Jiang Fu, Lin Chen, Hong-Feng Yuan, Yun-Fang Wang, Xin-Long Yan, Ying-Chen Xu, Quan Zeng, Wen Yue and Xue-Tao Pei

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24562

  11. Liver Injury/Regeneration

    1. Top of page
    2. Obituary
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Steatohepatits/Metabolic Liver Disease
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Liver Injury/Regeneration
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
      Hepatocytes internalize trophic receptors at large endocytic “Hot Spots” (pages 1819–1829)

      Hong Cao, Eugene W. Krueger and Mark A. McNiven

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24572

    2. You have free access to this content
      Identification and expansion of a unique stem cell population from adult mouse gallbladder (pages 1830–1841)

      Rohan Manohar, Junji Komori, Lynda Guzik, Donna B. Stolz, Uma R. Chandran, William A. LaFramboise and Eric Lagasse

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24568

  12. Reviews

    1. Top of page
    2. Obituary
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Steatohepatits/Metabolic Liver Disease
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Liver Injury/Regeneration
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
      Cancer surveillance in patients with primary sclerosing cholangitis (pages 1842–1852)

      Nataliya Razumilava, Gregory J. Gores and Keith D. Lindor

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24570

    2. You have free access to this content
      Ductular reactions in human liver: Diversity at the interface (pages 1853–1863)

      Annette S. H. Gouw, Andrew D. Clouston and Neil D. Theise

      Version of Record online: 13 OCT 2011 | DOI: 10.1002/hep.24613

    3. You have free access to this content
      Intensive care of the patient with cirrhosis (pages 1864–1872)

      Jody C. Olson, Julia A. Wendon, David J. Kramer, Vicente Arroyo, Rajiv Jalan, Guadalupe Garcia-Tsao and Patrick S. Kamath

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24622

  13. Hepatology Elsewhere

    1. Top of page
    2. Obituary
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Steatohepatits/Metabolic Liver Disease
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Liver Injury/Regeneration
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
      Opening the door for hepatitis C virus infection in genetically humanized mice (pages 1873–1875)

      Mirjam B. Zeisel, Daniel Da Costa and Thomas F. Baumert

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24603

    2. You have free access to this content
      The long and the short of interferon-gamma–inducible protein 10 in hepatitis C virus infection (pages 1875–1879)

      Mark D. Gorrell, Amany Zekry, Geoffrey W. McCaughan and Andrew Lloyd

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24600

    3. You have free access to this content
    4. You have free access to this content
      Boceprevir (Victrelis) for HCV: V is for victory and very complex (pages 1882–1886)

      Michael Charlton and Michael D. Leise

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24648

      Corrected by:

      Correction: Corrections: Boceprevir (Victrelis) for HCV: V is for victory and very complex

      Vol. 54, Issue 6, 2280, Version of Record online: 30 NOV 2011

  14. Image of the Month

    1. Top of page
    2. Obituary
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Steatohepatits/Metabolic Liver Disease
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Liver Injury/Regeneration
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
  15. Correspondence

    1. Top of page
    2. Obituary
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Steatohepatits/Metabolic Liver Disease
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Liver Injury/Regeneration
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      Reply: (pages 1889–1890)

      Chao-Wei Hsu and Chau-Ting Yeh

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24719

    3. You have free access to this content
      Targeting angiogenesis in chronic liver diseases with portal hypertension: anti–placenta growth factor inhibitor or multikinase inhibitor sorafenib? (pages 1890–1891)

      Romain Coriat, Olivier Mir, François Goldwasser, Stanislas Pol and Stanislas Chaussade

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24688

    4. You have free access to this content
      Reply: (page 1891)

      Isabelle Colle and Christophe Van Steenkiste

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24729

    5. You have free access to this content
      Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short-term and long-term outcomes (pages 1891–1892)

      Diarmaid D. Houlihan, Laurence J. Hopkins, Shankar X. Suresh, Matthew J. Armstrong and Philip N. Newsome

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24722

    6. You have free access to this content
      Reply: (page 1892)

      Liang Peng and Zhi-liang Gao

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24728

    7. You have free access to this content
      Seven cases of autoimmune hepatitis that developed after drug-induced liver injury (pages 1892–1893)

      Kazushi Sugimoto, Takeshi Ito, Norihiko Yamamoto and Katsuya Shiraki

      Version of Record online: 9 AUG 2011 | DOI: 10.1002/hep.24513

    8. You have free access to this content
      Polynesian ecology determines seasonality of biliary atresia (pages 1893–1894)

      Muriel Girard, Anne-Sophie Jannot, MArianne Besnard, Anne-Louise Leutenegger, Emmanuel Jacquemin, Stanislas Lyonnet and Alexandra Henrion-Caude

      Version of Record online: 28 OCT 2011 | DOI: 10.1002/hep.24534

    9. You have free access to this content
      Cell line misidentification: The case of the Chang liver cell line (pages 1894–1895)

      Qiang Gao, Xiao-Ying Wang, Jian Zhou and Jia Fan

      Version of Record online: 30 JUN 2011 | DOI: 10.1002/hep.24475

SEARCH

SEARCH BY CITATION